Mark Waltham
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 6
- Protease and Inhibitor Mechanisms 4
- Molecular Biology top 2%
- Biochemical and Molecular Research 7
- Oncology top 2%
- Cancer Cells and Metastasis 16
- Cancer-related Molecular Pathways 4
- Cell Biology top 5%
- Immunology and Allergy top 5%
-
- Chronic Lymphocytic Leukemia Research 6
-
- Advanced Proteomics Techniques and Applications 5
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- John N. WeinsteinUwe ScherfTimothy G. MyersDavid BotsteinMichael B. EisenPatrick O. BrownDouglas T. RossErik W. Thompson
- Journals
- Clinical & Experimental Metastasis (6 papers)Cancer Research (4 papers)Electrophoresis (4 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Waltham
68 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 858
- Molecular Biology 3.9k
- Oncology 1.3k
- Cell Biology 399
- Immunology and Allergy 136
Countries citing papers authored by Mark Waltham
This map shows the geographic impact of Mark Waltham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Waltham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Waltham more than expected).
Fields of papers citing papers by Mark Waltham
This network shows the impact of papers produced by Mark Waltham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Waltham. The network helps show where Mark Waltham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Waltham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 14 | |
| 2 | Plasma Cell-Free DNA (cfDNA) Concentration and Outcomes in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Patients Treated with Androgen Receptor Signalling Inhibitors (ARSIs) | 2018 | 1 |
| 3 | 2017 | 49 | |
| 4 | Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor | 2013 | 1 |
| 5 | 2013 | 95 | |
| 6 | 2007 | 67 | |
| 7 | 2007 | 45 | |
| 8 | 2006 | 7 | |
| 9 | The HSP90 pharmacological inhibitor, 17-AAG, enhances breast-bone metastasis in a nude mouse model and stimulates in vitro and in vivo osteoclast formation | 2005 | 1 |
| 10 | 2004 | 57 | |
| 11 | Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties | 2004 | 6 |
| 12 | 2002 | 12 | |
| 13 | Systematic variation in gene expression patterns in human cancer cell linesbreakdown → | 2000 | 1634 |
| 14 | 1997 | 11 | |
| 15 | 1997 | 70 | |
| 16 | 1996 | 28 | |
| 17 | 1994 | 1 | |
| 18 | 1993 | 3 | |
| 19 | 1989 | 3 | |
| 20 | 1988 | 8 |
About Mark Waltham
Mark Waltham is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 72 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (16 papers), Biochemical and Molecular Research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Genomics and Diagnostics (6 papers), Advanced Proteomics Techniques and Applications (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (858 citations), Molecular Biology (3.9k citations) and Oncology (1.3k citations). Mark Waltham has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include John N. Weinstein, Uwe Scherf, Timothy G. Myers, David Botstein, Michael B. Eisen, Patrick O. Brown, Douglas T. Ross, Erik W. Thompson, Jae K. Lee and Charles M. Perou. Their work appears in journals such as Clinical & Experimental Metastasis, Cancer Research, Electrophoresis, Molecular Pharmacology and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.